Literature DB >> 19895343

Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication.

Sima Shelly Toussi1, Aviva Joseph, Jian Hua Zheng, Monica Dutta, Laura Santambrogio, Harris Goldstein.   

Abstract

To delineate the mechanistic basis for the epidemiological association between methamphetamine use and accelerated progression to AIDS, we evaluated the direct in vitro and in vivo effects of methamphetamine on HIV-1 replication. Methamphetamine administration significantly increased HIV-1 production by both HIV-infected monocytes and CD4 T lymphocytes in vitro. In addition, in vivo methamphetamine treatment increased HIV production and viremia in mice transgenic for a replication-competent HIV provirus and human cyclin T1. Methamphetamine activated transcription of the HIV long terminal repeat (LTR) regulatory region, was associated with nuclear translocation of NF-kappaB. Our results provide further insights into the mechanisms by which methamphetamine accelerates disease course in HIV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895343      PMCID: PMC2828189          DOI: 10.1089/aid.2008.0282

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  16 in total

1.  Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis.

Authors:  Audrey Varin; Sunil K Manna; Vincent Quivy; Anne-Zélie Decrion; Carine Van Lint; Georges Herbein; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

2.  Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia: a new in vivo system for studying the postintegration phase of HIV replication.

Authors:  J Browning Paul; E J Wang; M Pettoello-Mantovani; C Raker; S Yurasov; M M Goldstein; J W Horner; J Chan; H Goldstein
Journal:  AIDS Res Hum Retroviruses       Date:  2000-03-20       Impact factor: 2.205

3.  Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells.

Authors:  Y W Lee; B Hennig; J Yao; M Toborek
Journal:  J Neurosci Res       Date:  2001-11-15       Impact factor: 4.164

4.  Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection.

Authors:  J Browning; J W Horner; M Pettoello-Mantovani; C Raker; S Yurasov; R A DePinho; H Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles.

Authors:  Steven Shoptaw; Cathy J Reback; Thomas E Freese
Journal:  J Addict Dis       Date:  2002

7.  Methamphetamine enhances HIV infection of macrophages.

Authors:  Hao Liang; Xu Wang; Hui Chen; Li Song; Li Ye; Shi-Hong Wang; Yan-Jian Wang; Lin Zhou; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

8.  Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy.

Authors:  Ronald J Ellis; Meredith E Childers; Mariana Cherner; Deborah Lazzaretto; Scott Letendre; Igor Grant
Journal:  J Infect Dis       Date:  2003-12-08       Impact factor: 5.226

9.  Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas.

Authors:  Hanne Thiede; Linda A Valleroy; Duncan A MacKellar; David D Celentano; Wesley L Ford; Holly Hagan; Beryl A Koblin; Marlene LaLota; William McFarland; Douglas A Shehan; Lucia V Torian
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

10.  Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice.

Authors:  Qianli Yu; Dongqin Zhang; Michael Walston; Jin Zhang; Yingyin Liu; Ronald R Watson
Journal:  Int Immunopharmacol       Date:  2002-06       Impact factor: 4.932

View more
  36 in total

1.  Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages.

Authors:  Jessica L Reynolds; Wing Cheung Law; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Ken-Tye Yong; Rui Hui; Paras N Prasad; Stanley A Schwartz
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-12       Impact factor: 4.147

Review 2.  Modulation of intracellular restriction factors contributes to methamphetamine-mediated enhancement of acquired immune deficiency syndrome virus infection of macrophages.

Authors:  Xu Wang; Yizhong Wang; Li Ye; Jieliang Li; Yu Zhou; Sinem Sakarcan; Wenzhe Ho
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.

Authors:  Emily S Wires; David Alvarez; Curtis Dobrowolski; Yun Wang; Marisela Morales; Jonathan Karn; Brandon K Harvey
Journal:  J Neurovirol       Date:  2012-05-22       Impact factor: 2.643

4.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

5.  Morphine and galectin-1 modulate HIV-1 infection of human monocyte-derived macrophages.

Authors:  Jessica L Reynolds; Wing Cheung Law; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Manoj J Mammen; Ken-Tye Yong; Rui Hui; Paras N Prasad; Stanley A Schwartz
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

6.  Preintervention Profiles of Information, Motivational, and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men.

Authors:  Tyrel J Starks; Brett M Millar; Jonathan M Lassiter; Jeffrey T Parsons
Journal:  AIDS Patient Care STDS       Date:  2017-01-16       Impact factor: 5.078

Review 7.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

Review 8.  The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis.

Authors:  Ryan Colby Passaro; Jui Pandhare; Han-Zhu Qian; Chandravanu Dash
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-08       Impact factor: 4.147

9.  Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression.

Authors:  Chinmay K Mantri; Jyoti V Mantri; Jui Pandhare; Chandravanu Dash
Journal:  Am J Pathol       Date:  2013-10-26       Impact factor: 4.307

10.  Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.

Authors:  Steffanie A Strathdee; Jamila K Stockman
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.